E Fund Management’s Acceleron Pharma XLRN Stock Holding History

E Fund Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,302	Closed	-$224K	–	320
2021 Q3	$224K	Buy	+1,302	New	+$170K	0.01%	217

E Fund Management's XLRN Position: Q4 2021 in Review

E Fund Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,302 shares — an estimated $224K sold.

E Fund Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $224K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

E Fund Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
E Fund Management sold 1,302 Acceleron Pharma shares in Q4 2021, an estimated $224K.
E Fund Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
E Fund Management's Acceleron Pharma position peaked at $224K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on E Fund Management's 13F filing for Q4 2021, filed 11 Feb 2022.